156 related articles for article (PubMed ID: 7602463)
21. Preparation of poly(D,L-lactide) and copoly(lactide-glycolide) microspheres of uniform size.
Shiga K; Muramatsu N; Kondo T
J Pharm Pharmacol; 1996 Sep; 48(9):891-5. PubMed ID: 8910847
[TBL] [Abstract][Full Text] [Related]
22. Oxaliplatin loaded PLAGA microspheres: design of specific release profiles.
Lagarce F; Cruaud O; Deuschel C; Bayssas M; Griffon-Etienne G; Benoit J
Int J Pharm; 2002 Aug; 242(1-2):243-6. PubMed ID: 12176255
[TBL] [Abstract][Full Text] [Related]
23. Preparation of gelatin microparticles by co-lyophilization with poly(ethylene glycol): characterization and application to entrapment into biodegradable microspheres.
Morita T; Horikiri Y; Suzuki T; Yoshino H
Int J Pharm; 2001 May; 219(1-2):127-37. PubMed ID: 11337173
[TBL] [Abstract][Full Text] [Related]
24. Porous biodegradable microparticles for delivery of pentamidine.
Mandal TK; Bostanian LA; Graves RA; Chapman SR; Idodo TU
Eur J Pharm Biopharm; 2001 Jul; 52(1):91-6. PubMed ID: 11438428
[TBL] [Abstract][Full Text] [Related]
25. Optimization of preparative conditions for polylactide (PLA) microspheres containing ovalbumin.
Uchida T; Yoshida K; Ninomiya A; Goto S
Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1569-73. PubMed ID: 7586084
[TBL] [Abstract][Full Text] [Related]
26. Long-term release of clodronate from biodegradable microspheres.
Perugini P; Genta I; Conti B; Modena T; Pavanetto F
AAPS PharmSciTech; 2001 Jul; 2(3):E10. PubMed ID: 14727869
[TBL] [Abstract][Full Text] [Related]
27. Study on in vitro release patterns of fentanyl-loaded PLGA microspheres.
Seo SA; Khang G; Rhee JM; Kim J; Lee HB
J Microencapsul; 2003; 20(5):569-79. PubMed ID: 12909542
[TBL] [Abstract][Full Text] [Related]
28. The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method.
Coombes AG; Yeh MK; Lavelle EC; Davis SS
J Control Release; 1998 Mar; 52(3):311-20. PubMed ID: 9743451
[TBL] [Abstract][Full Text] [Related]
29. Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats.
Menei P; Boisdron-Celle M; Croué A; Guy G; Benoit JP
Neurosurgery; 1996 Jul; 39(1):117-23; discussion 123-4. PubMed ID: 8805147
[TBL] [Abstract][Full Text] [Related]
30. Precise control of PLG microsphere size provides enhanced control of drug release rate.
Berkland C; King M; Cox A; Kim K; Pack DW
J Control Release; 2002 Jul; 82(1):137-47. PubMed ID: 12106984
[TBL] [Abstract][Full Text] [Related]
31. Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?
Péan JM; Boury F; Venier-Julienne MC; Menei P; Proust JE; Benoit JP
Pharm Res; 1999 Aug; 16(8):1294-9. PubMed ID: 10468034
[TBL] [Abstract][Full Text] [Related]
32. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
33. Submicronparticles from biodegradable polymers.
Jobmann M; Rafler G
Int J Pharm; 2002 Aug; 242(1-2):213-7. PubMed ID: 12176249
[TBL] [Abstract][Full Text] [Related]
34. Characterization of ciclosporin A loaded poly (D,L lactide-co-glycolide) microspheres using modulated temperature differential scanning calorimetry.
Passerini N; Craig DQ
J Pharm Pharmacol; 2002 Jul; 54(7):913-9. PubMed ID: 12162709
[TBL] [Abstract][Full Text] [Related]
35. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
Xinteng Z; Weisan P; Ruhua Z; Feng Z
Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
[TBL] [Abstract][Full Text] [Related]
36. In vitro evaluation of gentamicin released from microparticles.
Blanco-Príeto MJ; Lecaroz C; Renedo MJ; Kunkova J; Gamazo C
Int J Pharm; 2002 Aug; 242(1-2):203-6. PubMed ID: 12176247
[TBL] [Abstract][Full Text] [Related]
37. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.
Uchida T; Goto S; Foster TP
J Pharm Pharmacol; 1995 Jul; 47(7):556-60. PubMed ID: 8568620
[TBL] [Abstract][Full Text] [Related]
38. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres.
Uchida T; Yagi A; Oda Y; Nakada Y; Goto S
Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):235-6. PubMed ID: 8582042
[TBL] [Abstract][Full Text] [Related]
39. Critical properties of lactide-co-glycolide polymers for the use in microparticle preparation by the aerosol solvent extraction system.
Engwicht A; Girreser U; Müller BW
Int J Pharm; 1999 Aug; 185(1):61-72. PubMed ID: 10425366
[TBL] [Abstract][Full Text] [Related]
40. Poly(lactide-co-glycolide) microparticles as systems for controlled release of proteins -- preparation and characterization.
Porjazoska A; Goracinova K; Mladenovska K; Glavas M; Simonovska M; Janjević EI; Cvetkovska M
Acta Pharm; 2004 Sep; 54(3):215-29. PubMed ID: 15610618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
